Browse all
Channels
All
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
Advertising options
About
Home
news
brim biotech submits us phase 3 clinical trial protocol for brm421 in the treatment of dry eye disea
SHARE
Jul. 6, 2025
Courtesy of
Contact supplier
Drop file here or browse
Yes, please send to similar suppliers.
SEND
Stay in the loop!
Select your areas of interest to receive industry updates.
JOIN OUR MAILING LIST